Skip to content
Business
Prognosis

Moderna Seeks U.S. Clearance of Covid Shot for Young Kids

  • Pressure mounting on regulators to give toddlers protection
  • Two doses of vaccine shown providing strong immune response
Video player cover image
Moderna Is Waiting on Vaccine Orders From U.S.
Updated on

Moderna Inc. applied for emergency use authorization for its Covid-19 vaccine in children from six months to under 6 years old after a successful trial showed two doses generate high levels of antibodies to the virus.

The highly anticipated application comes just over a month after Moderna said a large trial showed two low doses of its vaccine produced powerful immune responses in young kids. Even though its effectiveness against omicron-related infections is modest, the application will put tremendous pressure on the Food and Drug Administration to quickly make a decision on whether to authorize it.